Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

21 May 2009

Immunization of recipient with donor immobilized non-dividing splenocytes significantly prolongs allogeneic heart survival

W Olszewski, M Moscicka, H Dolezyczek

Ann Transplant 2009; 14(1): 68-68 :: ID: 880448

Abstract

Background: On the contact of recipient with the donor, transplantation antigens evoke humoral and cellular rejection reaction. Blood transfusions, pregnancy and previous grafts may cross-reactively immunize recipient against donor antigens. In all the mentioned cases donor antigens are mainly supplied by "passenger cells". These cells colonize recipient lymphoid tissues and produce progenies. This enhances immune response and subsequently rejection. The question arises whether metabolically immobilized non-dividing (mummified) donor cells administered to recipient prior to transplantation may mitigate rejection reaction, presumably by evoking formation of enhancing antibodies. Immobilisation can be achieved by treating the donor cells with pulverized NaCl. These cells retain their molecular structure but do not divide. Aim: to immunise recipient with donor NaCl-treated splenocytes prior to heart transplantation.
Material/Methods: BN rat spleen fragments were placed in pulverized NaCl and 7 d later implanted intraperitoneally into LEW rat on d 0 and 7. Seven days later heart TX from BN was performed. Non-immunized rats served as controls. No immunosuppression was given.
Results: the immunised LEW did not reject BN heart until d 20 (20±2),
whereas control rats rejected the graft within 6±1 days (p<0.001). Histology
showed that rejected hearts from immunised recipients' revealed hypertrophied muscle with few infiltrates, in contrast to controls with dense infiltrates and necrotic areas. Deposition of IgG in graft vessels could be seen on immunohistochemical pictures.
Conclusions: Immunisation of recipient with mummified splenocytes retaining their molecular structure may be responsible for prolongation of allogeneic heart survival.

Keywords: Heart Transplantation, Immunosuppression, Tissue Transplantation

Add Comment 0 Comments

In Press

12 Feb 2024 : Original article  

No Prognostic Impact of Graft-to-Recipient Weight Ratio on Hepatocellular Carcinoma Recurrence Following Li...

Ann Transplant In Press; DOI: 10.12659/AOT.942767  

21 Feb 2024 : Original article  

Use of LCP-Tacrolimus (LCPT) in Kidney Transplantation: A Delphi Consensus Survey of Expert Clinicians

Ann Transplant In Press; DOI: 10.12659/AOT.943498  

Most Viewed Current Articles

05 Apr 2022 : Original article  

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

12 Jan 2022 : Original article  

Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...

DOI :10.12659/AOT.934738

Ann Transplant 2022; 27:e934738

22 Nov 2022 : Original article  

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

15 Mar 2022 : Case report  

Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...

DOI :10.12659/AOT.935860

Ann Transplant 2022; 27:e935860

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358